Goodman, S.G., Aylward, P.E., Szarek, M., Viigimaa, M. et al.

Effects of alirocumab on cardiovascular events after coronary bypass surgery

author

Goodman, Shaun G.

Aylward, Philip E.

Szarek, Michael

Viigimaa, Margus

statement of authorship

Goodman, Shaun G.; Aylward, Philip E.; Szarek, Michael; Chumburidze, Vakhtang; Bhatt, Deepak L.; Bittner, Vera A.; Diaz, Rafael; Edelberg, Jay M.; Hanotin, Corinne; Harrington, Robert A.; Jukema, J. Wouter; Kedev, Sasko; Letierce, Alexia; Moryusef, Angele; Pordy, Robert; Lopez, Gabriel Arturo Ramos; Roe, Matthew T.; Viigimaa, Margus et al.

source

Journal of the American College of Cardiology

journal volume number month

vol. 74, 9

year of publication

2019

pages

p. 1177−1186 : ill

url

https://doi.org/10.1016/j.jacc.2019.07.015

subject term

kolesterool

ravimid

koronaararterid

südame-veresoonkonna haigused

lipiidid

biokeemilised aspektid

keyword

alirocumab

cholesterol

coronary artery bypass graft

lipids

proprotein convertase subtilisin−kexin type (9PCSK9)

ISSN

0735-1097

notes

Includes bibliogr

TTÜ department

tervisetehnoloogiate instituut

language

inglise

Goodman, S.G., Aylward, P.E., Szarek, M., Viigimaa, M. et al. Effects of alirocumab on cardiovascular events after coronary bypass surgery // Journal of the American College of Cardiology (2019) vol. 74, 9, p. 1177−1186 : ill. https://doi.org/10.1016/j.jacc.2019.07.015